Form Type: 4

SEC EDGAR Link
Accession Number:0001567619-19-018220
Date:2019-09-10
Issuer: STOKE THERAPEUTICS, INC. (STOK)
Original Submission Date:

Reporting Person:

KRAINER ADRIAN R.
C/O STOKE THERAPEUTICS, INC.
45 WIGGINS AVENUE BEDFORD, MA 01730

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
DIRECTOR STOCK OPTION (RIGHT TO BUY) 28.8 2019-09-10 deemed execution date A 14,777 (a) 2029-09-09 common stock 14,777 $28.80 14,777 direct
Footnotes
IDfootnote
f1 this option vests 100% and becomes exercisable on june 21, 2020, subject to reporting person's continued service through such vesting date.
WhaleWisdom Logo

Elevate your investments